| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/19/2007 | EP1284729A4 A(beta)42 lowering agents |
| 12/19/2007 | EP1032556B1 Pharmaceutically active compounds and methods of use |
| 12/19/2007 | EP1005341B1 Il-8 receptor antagonists |
| 12/19/2007 | EP0804440B1 Tricyclic benzazepine vasopressin antagonists |
| 12/19/2007 | EP0594669B2 Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
| 12/19/2007 | CN101090902A Cgrp受体拮抗剂 Cgrp receptor antagonists |
| 12/19/2007 | CN101090898A 5-HT7 receptor antagonists |
| 12/19/2007 | CN101090896A Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
| 12/19/2007 | CN101090895A Aryl sulphonamide modulators |
| 12/19/2007 | CN101090894A Macrocyclic compounds and compositions useful as BACE inhibitors |
| 12/19/2007 | CN101090883A Substituted hydroxyethylamines |
| 12/19/2007 | CN101090731A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 12/19/2007 | CN101090726A Cladribine regimen for treating multiple sclerosis |
| 12/19/2007 | CN101090722A 镇痛剂 Analgesics |
| 12/19/2007 | CN101090721A Selective serotonin receptor inverse agonists as therapeutics for disease |
| 12/19/2007 | CN101090713A Method of providing fast relief to a user of a nicotine chewing gum |
| 12/19/2007 | CN101090643A Temporally meal menu for infants |
| 12/19/2007 | CN101088565A Use of miRNA-34a |
| 12/19/2007 | CN101088543A Oral medicine for treating insomnia |
| 12/19/2007 | CN101088538A Chinese medicine for nourishing brain and recovering vitality |
| 12/19/2007 | CN101088530A Medicine micropill and its prepn process |
| 12/19/2007 | CN101088503A Freeze dried nimodipine powder for injection and its prepn |
| 12/19/2007 | CN101088499A Dry asarol emulsion and its prepn and application |
| 12/19/2007 | CN101088498A Application of bakuchiol compound |
| 12/19/2007 | CN100355756C Therapeutic agent for schizophrenia |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity |
| 12/19/2007 | CN100355433C Chinese medicine preparation for treating insomnia |
| 12/19/2007 | CN100355426C Disodium adenosine triphosphate solid composition for injection and its preparing method |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309789 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309719 Stabilized pharmaceutical preparation of gamma-aminobutyric acid derivatives and process for preparing the same |
| 12/18/2007 | US7309706 Method for the treatment of diseases requiring inhibition or a reduction in the activity of pH value-regulating bicarbonate transporter proteins |
| 12/18/2007 | US7309705 7-carboxamido- or sulfonamido-substituted: 2-Phenyl-3-cyclopropyl-7-(4-pyridylcarboxamido)pyrazolo[1.5a]pyrimidine; anticarcinogenic, antiinflammatory, neurodegenerative agent; arthritis, Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases; with other active compounds |
| 12/18/2007 | US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 12/18/2007 | US7309690 Parenterally or nasally administering zinc-free immune-system-inactive thymulin peptide analogue: Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asp; migraine, sciatica, neuropathy and inflammatory pain |
| 12/18/2007 | US7309497 Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients |
| 12/18/2007 | CA2489763C Pharmaceutical salts of reboxetine |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2418479C Prodrugs of betulinic acid derivatives for the treatment of cancer |
| 12/18/2007 | CA2233042C Specific binding members for human transforming growth factor beta; materials and methods |
| 12/13/2007 | WO2007143422A2 Substituted pyridyl amide compounds as modulators of the histamine h3 receptor |
| 12/13/2007 | WO2007143267A2 Treatment of pain disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine and its formamide |
| 12/13/2007 | WO2007142924A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity |
| 12/13/2007 | WO2007142923A1 Mif inhibitors for treating neuropathic pain and associated syndromes |
| 12/13/2007 | WO2007142905A2 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 12/13/2007 | WO2007142585A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 12/13/2007 | WO2007142584A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia |
| 12/13/2007 | WO2007142583A1 Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia. |
| 12/13/2007 | WO2007142577A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor |
| 12/13/2007 | WO2007142576A1 2-thioxanthine derivatives acting as mpo-inhibitors |
| 12/13/2007 | WO2007142431A1 New non-peptide compounds, process for the preparation thereof and pharmaceutical composition comprising the same |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 12/13/2007 | WO2007142295A1 Novel tape preparation |
| 12/13/2007 | WO2007142253A1 2-cyanopyrrolidine derivative |
| 12/13/2007 | WO2007142217A1 1-phenylpyridone derivative |
| 12/13/2007 | WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food |
| 12/13/2007 | WO2007142028A1 Pyrrolidine analogue for preventing neurogenic pain and method for production thereof |
| 12/13/2007 | WO2007141974A1 Nonhuman model animal of hypertension |
| 12/13/2007 | WO2007141971A1 Dna encoding polypeptide capable of modulating muscle-specific tyrosine kinase activity |
| 12/13/2007 | WO2007141926A1 Extended amyloid beta production inhibitor |
| 12/13/2007 | WO2007141571A2 Aminothiazole derivatives as inhibitors of mark |
| 12/13/2007 | WO2007141343A1 Phenyl pyrrole aminoguanidine derivatives |
| 12/13/2007 | WO2007141328A1 Low dose sublingual tablets of opioid analgesics and preparation process |
| 12/13/2007 | WO2007141267A1 N- (phenylmethyl) -2- (1h-pyraz0l-4-yl) acetamide derivatives as p2x7 antagonists for the treatment of pain, inflammation and neurodegeneration |
| 12/13/2007 | WO2007141002A1 Co-crystals of pyrrolidinones |
| 12/13/2007 | WO2007140980A1 Pyrrolidine derivatives useful as bace inhibitors |
| 12/13/2007 | WO2007119001A3 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof |
| 12/13/2007 | WO2007110730A3 Varenicline standards and impurity controls |
| 12/13/2007 | WO2007107291A3 Agents for influencing receptors and consequences thereof |
| 12/13/2007 | WO2007105171A3 Killing of selected cells |
| 12/13/2007 | WO2007103776A3 A2a adenosine receptor antagonists |
| 12/13/2007 | WO2007078813A3 2-AMINO-5-PIPERIDINYLIMIDAZOLONE COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION |
| 12/13/2007 | WO2007038115A3 Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients |
| 12/13/2007 | WO2006097358A3 Analgesic combination of sodium channel blockers with opioid antagonists |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287931 Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
| 12/13/2007 | US20070287753 Intranasal Administration of Ketamine to Treat Depression |
| 12/13/2007 | US20070287728 Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monomine Neurotransmitter Re-Uptake Inhibitors |
| 12/13/2007 | US20070287721 Pyrazolopyridinyl pyridine |
| 12/13/2007 | US20070287716 Pyrimidine and Quinoline Potentiators of Metabotropic Glutamate Receptors |
| 12/13/2007 | US20070287707 Phosphodiesterase 10 inhibitors |
| 12/13/2007 | US20070287706 Certain substituted quinolones, compositions, and uses thereof |
| 12/13/2007 | US20070287705 Crf Receptor Antagonists and Methods Relating Thereto |
| 12/13/2007 | US20070287696 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 12/13/2007 | US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 12/13/2007 | US20070287666 Modulator of gamma-secretase |
| 12/13/2007 | US20070287665 Urotensin-II agonists and antagonists |
| 12/13/2007 | US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286911 Huperzia serrate (thunb.) trev. composition comprising compounded huperzine a and huperzine b and methods for preparing it |
| 12/13/2007 | US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1) |
| 12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
| 12/13/2007 | US20070286851 Method of Identifying Modulators of NOGO-Functions |
| 12/13/2007 | US20070286845 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 12/13/2007 | US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof |
| 12/13/2007 | CA2688485A1 Phenyl pyrrole aminoguanidine derivatives |
| 12/13/2007 | CA2687124A1 Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia |